Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Merck KGaA : Effect Pigments for Architecture: Merck Exhibits at the Middle East Coatings Show 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/05/2012 | 10:24am CET

Darmstadt/Germany, March 5, 2012 - Merck will be presenting its effect pigments for architecture at the Middle East Coatings Show in Dubai from March 12 to 14, 2012. This exhibition is the most important platform for the coatings sector in the Middle East and the Gulf region. The focus of the exhibition will be on architectural applications, which have been seeing rapid growth in the region for the past several years. The trend toward gold and silver shades, which can currently be seen in lifestyle products and interior designs, is also being reflected in architecture.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MERCK KGAA
01/20 MERCK : and Genea Open Centre of Excellence for Fertility
01/19 MERCK KGAA : Darmstadt, Germany, Licenses Four Oncology Research and Development..
01/19 MERCK KGAA : Darmstadt, Germany, and Palantir Launch New Healthcare Acceleration..
01/19 MERCK KGAA : Darmstadt, Germany Licenses Four Oncology Research and Development ..
01/19 MERCK : CLEARink Displays and Merck KGaA, Darmstadt, Germany, Sign Development A..
01/19 MERCK : EMD Serono and MD Anderson Cancer Center Enter Three-Year Strategic Coll..
01/18 MERCK : Launches First Commercial Screening Service to Predict Multiple Sources ..
01/18 MERCK : MilliporeSigma Kicks Off Year-Long 'Curiosity Cube' Tour
01/18 MERCK : And Palantir Technologies Inc Agree On Cancer Data Analysis Pact
01/17 MERCK : Moves Executives Between Businesses and Group Functions
More news
Sector news : Specialty & Advanced Pharmaceuticals
01/20 European shares ease ahead of Trump inauguration
01/20 Bristol-Myers shares fall on lung cancer timeline setback
01/19DJRival to EpiPen Allergy Treatment to Return to Market--Update
01/19DJRival to EpiPen Allergy Treatment to Return to Market
01/19 Davos CEOs 'go local' on supply chain in Trump era
More sector news : Specialty & Advanced Pharmaceuticals
News from SeekingAlpha
01/18 Astra's Mystic Mystery And Other Surprises In Store
01/12 Vertex And German Merck Find Their Perfect Fit
01/12 JPMorgan Day Three Roundup - Trump Reminds The Sector Who's In Charge
01/11 Vertex to collaborate with Germany's Merck in oncology
01/10 German Merck Unveils Its Secret Weapon
Advertisement
Financials (€)
Sales 2016 15 065 M
EBIT 2016 3 512 M
Net income 2016 1 787 M
Debt 2016 11 028 M
Yield 2016 1,20%
P/E ratio 2016 24,21
P/E ratio 2017 22,84
EV / Sales 2016 1,61x
EV / Sales 2017 1,43x
Capitalization 13 273 M
More Financials
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 108 €
Spread / Average Target 5,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA3.58%14 201
ABBVIE INC-2.35%99 375
KYOWA HAKKO KIRIN CO L..-1.55%8 009
JAZZ PHARMACEUTICALS P..13.62%7 419
MALLINCKRODT PLC-7.51%4 828
ZHANGZHOU PIENTZEHUANG..-1.31%3 967
More Results